Quick Takeaways
- PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G for KESTRA MEDICAL TECHNOLOGIES COMMON STOCK (KMTS).
- Disclosed ownership: 7.5%.
- Date of event: 31 Dec 2025.
PRICE T ROWE ASSOCIATES INC /MD/ - 31 Dec 2025 SCHEDULE 13G Report for KESTRA MEDICAL TECHNOLOGIES COMMON STOCK (KMTS)
- Filing Manager
- PRICE T ROWE ASSOCIATES INC /MD/
- Reporting Manager
- T. Rowe Price Associates, Inc.
- Symbol
- KMTS
- Shares outstanding
- 58,259,053 shares
- Disclosed Ownership
- 4,369,429 shares
- Ownership
- 7.5%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 10:26:21 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PRICE T ROWE ASSOCIATES INC /MD/ disclosed 7.5% ownership in KESTRA MEDICAL TECHNOLOGIES COMMON STOCK (KMTS) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 10:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 7.5% | 4,369,429 | 4,208,056 | 0 | Ellen York | Vice President |